BioLongevity Labs Revolutionizes Peptide Delivery with Launch of BioStrips™: World's First Peptide-Powered Sublingual Buccal Strips
Written by Wyles Daniel
Breakthrough InstaRelease™ technology delivers research peptides directly into the bloodstream for rapid, targeted absorption
AKRON, OH - JUNE 13, 2025 - BioLongevity Labs, a pioneering venture in advanced peptide science, today announced the groundbreaking launch of BioStrips™—the world's first peptide-powered sublingual buccal strips featuring proprietary InstaRelease™ technology.
This revolutionary delivery system, created and patented by InstaMed™, represents a paradigm shift in peptide administration, designed to supercharge research results in seconds through instant dissolution and direct bloodstream delivery.
Founded by health optimization experts Jay Campbell, Josh Felber, and Hunter Williams, BioLongevity Labs continues to push the boundaries of peptide science with this latest innovation that bypasses traditional delivery limitations.
"BioStrips represents the next evolution in peptide research methodology," said Jay Campbell, co-founder and globally recognized health authority.
"We've eliminated the barriers that have historically limited peptide efficacy. This goes beyond convenience to deliver breakthrough outcomes through advanced delivery science."
Revolutionary InstaRelease™ Technology BioStrips distinguish themselves through breakthrough sublingual delivery that dissolves instantly, delivering peptides directly into the bloodstream for rapid, targeted action.
Unlike conventional methods that degrade through digestive processes, BioStrips bypass the gut entirely and work directly where it matters most.
These innovative strips utilize advanced formulation science to ensure optimal bioavailability and precise dosing.
Each strip is engineered for immediate dissolution through the oral mucosa, enabling peptides to enter systemic circulation within seconds rather than the delayed absorption seen with traditional delivery methods.
Comprehensive Research Peptide Portfolio
BioStrips are currently available in five precisely formulated research peptide variants:
- BPC-157 BioStrips: Designed for recovery and tissue repair research applications
- CJC-1295 BioStrips: Engineered for growth hormone research protocols
- GHK-Cu BioStrips: Formulated for cellular regeneration and anti-aging research
- PT-141 BioStrips: Developed for specialized research applications
- Thymosin Alpha 1 BioStrips: Created for immune system research studies
"BioStrips give researchers the speed and precision they need in their work, whether they're studying peptide absorption, investigating neural pathways, or exploring cellular mechanisms," explains Hunter Williams.
"The targeted action and rapid onset make this technology ideal for time-sensitive research applications."
Uncompromising Quality Standards
BioLongevity Labs, in partnership with InstaMed™, maintains exceptionally strict quality control for BioStrips manufacturing.
Each product is manufactured exclusively in the United States, with materials primarily sourced domestically.
Every production batch undergoes independent laboratory testing to verify over 99% purity, potency, and safety, with comprehensive Certificates of Authenticity (COA) provided to research facilities.
InstaMed™’s facility is NSF cGMP certified with meticulous manufacturing protocols at every production stage to ensure consistent quality.
State-of-the-art facilities utilize advanced chemistry and modern delivery technology, ensuring superior quality materials for scientific study.
Leadership Driving Scientific Innovation BioLongevity Labs' founding team brings decades of combined expertise to this breakthrough development:
- Jay Campbell: Five-time bestselling author and globally recognized authority in health optimization
- Josh Felber: Emmy Award winner and Inc. 5000 honoree with extensive business development experience
- Hunter Williams: Respected biohacker with specialized knowledge in peptide science and application
Transforming Research Capabilities The launch of BioStrips addresses critical limitations in peptide research by providing laboratories with a delivery method that maximizes bioavailability while minimizing variables that can affect research outcomes. The precision, pre-dosed, travel-friendly formulation, and consistent delivery make BioStrips an invaluable tool for advancing peptide science.
"We're seeing research facilities achieve results that were previously difficult to replicate due to delivery inconsistencies," notes Josh Felber.The company continues expanding its research-grade peptide offerings while advancing the science of optimized delivery systems.
"BioStrips provide the reliability and speed that serious research demands."
About BioLongevity Labs
BioLongevity Labs is dedicated to advancing peptide science through premium, US-manufactured research compounds for scientific laboratories. All products are rigorously tested for purity and efficacy, supporting cutting-edge research in health sciences. The company's BioStrips represent the latest innovation in peptide delivery technology, designed exclusively for qualified research facilities. For more information, visit BioLongevity Labs and Jay Campbell, email help@biolongevitylabs.com, or call 855-699-5333.
Media Contact:
Kayla Ricci
Publicist
484-947-6372
kayla@highkeyagency.com
